A significant advance in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This vital tumor protector protein is frequently inactivated in many types of cancer, leading uncontrolled cell https://mysitesname.com/story11930118/vhh-fragments-revive-the-p53-protein-a-new-pathway-for-cancer-management